Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

BACKGROUND: Women living with HIV (WLWH) are at higher risk of acquisition and progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination in this population is limited. METHODS: This phase IV randomized controlled observer-blind study assessed immunogenicity and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Folschweiller, Nicolas, Teixeira, Julio, Joshi, Smita, Goldani, Luciano Z, Supparatpinyo, Khuanchai, Basu, Partha, Chotpitayasunondh, Tawee, Chetchotisakd, Ploenchan, Ruxrungtham, Kiat, Roteli-Martins, Cecilia, Grinsztejn, Beatriz, Quintana, Silvana Maria, Kumarasamy, Nagalingeswaran, Poongulali, Selvamuthu, Kulkarni, Vinay, Lin, Lan, Datta, Sanjoy K, Descamps, Dominique, Dodet, Monique, Dubin, Gary, Friel, Damien, Hezareh, Marjan, Karkada, Naveen, Meric Camilleri, Dorothee, Poncelet, Sylviane, Salaun, Bruno, Tavares-da-Silva, Fernanda, Thomas-Jooris, Florence, Struyf, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329699/
https://www.ncbi.nlm.nih.gov/pubmed/32639485
http://dx.doi.org/10.1016/j.eclinm.2020.100353

Ejemplares similares

Ejemplares similares